找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Policy: Pharmaceutical Safety; June M. McKoy,Dennis P. West Book 2019 Springer Nature Switzerland AG 2019 Drug Safety.Health.Oncolo

[復(fù)制鏈接]
樓主: 從未迷惑
31#
發(fā)表于 2025-3-26 21:11:11 | 只看該作者
32#
發(fā)表于 2025-3-27 02:41:53 | 只看該作者
33#
發(fā)表于 2025-3-27 06:35:09 | 只看該作者
Current Topics in Behavioral Neurosciencese electronic health records. For victims of adverse drug reactions, tort lawsuits filed in the courts help compensate for the harm suffered and may also serve as warnings to manufacturers to improve drug safety to avoid future legal liability. While encouraging developments have occurred, new and ex
34#
發(fā)表于 2025-3-27 09:44:28 | 只看該作者
New Discoveries on the β-Hydride Eliminationerfeit products that compromise patient safety. The Food and Drug Administration plays a key role in preventing and managing pharmaceutical shortages, largely through regulations requiring early notification of manufacturing interruptions. Other proposed strategies similarly target upstream causes a
35#
發(fā)表于 2025-3-27 16:18:41 | 只看該作者
36#
發(fā)表于 2025-3-27 20:49:19 | 只看該作者
37#
發(fā)表于 2025-3-27 22:24:56 | 只看該作者
Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies,n, particularly for cancer patients. If counted as a separate cause of death, adverse drug reactions would represent the fourth leading cause of death in the United States. Several legal strategies are available to help mitigate their occurrences and to compensate victims for the harm that results f
38#
發(fā)表于 2025-3-28 03:13:31 | 只看該作者
39#
發(fā)表于 2025-3-28 08:50:18 | 只看該作者
The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety,s safety risks for patients and substantial burden on providers and the healthcare system. Multifaceted drivers of this complex problem include manufacturing disruptions, raw material shortages, regulatory issues, market dynamics, and limited financial incentives that reward quality and production o
40#
發(fā)表于 2025-3-28 11:19:38 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 04:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
呼伦贝尔市| 遂川县| 大化| 墨竹工卡县| 阳朔县| 罗城| 富民县| 扎鲁特旗| 潼南县| 朝阳市| 隆化县| 婺源县| 洞口县| 武城县| 城口县| 嵊州市| 阿鲁科尔沁旗| 遂宁市| 锦州市| 晋城| 万宁市| 临西县| 乡城县| 吴川市| 池州市| 绥中县| 元阳县| 邹城市| 吴江市| 武邑县| 德阳市| 靖远县| 沈丘县| 曲麻莱县| 九江市| 旬阳县| 常熟市| 珠海市| 拉孜县| 陵川县| 当雄县|